Research programme: dengue vaccine - European Vaccine Initiative/Nagasaki University/Institut Pasteur

Drug Profile

Research programme: dengue vaccine - European Vaccine Initiative/Nagasaki University/Institut Pasteur

Latest Information Update: 10 Nov 2015

Price : $50

At a glance

  • Originator Institut Pasteur; Nagasaki University School of Medicine
  • Class Dengue vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Research Dengue

Most Recent Events

  • 10 Nov 2015 Early research in Dengue (Prevention) in Japan (Parenteral)
  • 04 Nov 2015 European Vaccine Initiative, Nagasaki University and Institut Pasteur receives grant from the Global Health Innovative Technology Fund for dengue vaccine development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top